Research and Development

Catapults: supporting UK manufacturing growth

The National Composites Centre (NCC) say the iCAP programme "will bring composites into the digital age, increasing production rates and quality while improving efficiency and reducing cost" - image courtesy of NCC

Help is at hand for manufacturers seeking to invest in R&D around product and processes to drive growth. Peter Russell, head of manufacturing and industrials at Royal Bank of Scotland investigates how the Technology Strategy Board’s Catapult Centres provide manufacturers with a sound support package to ensure innovative ideas make it from drawing boards to market, while also challenging conventional wisdom on how UK manufacturing is done.

GW Pharamaceuticals cannabis-based treatments available

Marijuana plantation - photo courtesy of West Midlands Police
Posted on 18 Apr 2013 by Tim Brown

GW Pharmaceuticals, the biopharmaceutical company focused on developing cannabis-based therapeutics, has announced that Sativex, its treatment for spasticity in Multiple Sclerosis, has been determined by Advisory Council on Misuse of Drugs (ACMD) that has a low potential for abuse and low risk of diversion.